These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18068613)

  • 1. Losartan improves heart rate variability and heart rate turbulence in heart failure due to ischemic cardiomyopathy.
    Ozdemir M; Arslan U; Türkoğlu S; Balcioğlu S; Cengel A
    J Card Fail; 2007 Dec; 13(10):812-7. PubMed ID: 18068613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability in heart failure.
    Musialik-Łydka A; Sredniawa B; Pasyk S
    Kardiol Pol; 2003 Jan; 58(1):10-6. PubMed ID: 14502297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of heart rate turbulence by titrated beta-blocker therapy in patients with advanced congestive heart failure: positive correlation with enhanced vagal modulation of heart rate.
    Lin LY; Hwang JJ; Lai LP; Chan HL; Du CC; Tseng YZ; Lin JL
    J Cardiovasc Electrophysiol; 2004 Jul; 15(7):752-6. PubMed ID: 15250856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
    Belonje AM; Westenbrink BD; Voors AA; von Haehling S; Ponikowski P; Anker SD; van Veldhuisen DJ; Dickstein K
    Am Heart J; 2009 Jan; 157(1):91-6. PubMed ID: 19081402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and heart rate variability in patients with chronic heart failure.
    Straburzyńska-Migaj E; Ochotny R; Wachowiak-Baszyńska A; Straburzyńska-Lupa A; Leśniewska K; Wiktorowicz K; Cieśliński A
    Kardiol Pol; 2005 Nov; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of heart rate turbulence to severity of heart failure.
    Cygankiewicz I; Zareba W; Vazquez R; Vallverdu M; Cino J; Cinca J; Almendral J; Gonzalez Juanatey JR; Macaya C; Valdes M; Caminal P; Bayes de Luna A
    Am J Cardiol; 2006 Dec; 98(12):1635-40. PubMed ID: 17145225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in heart rate, heart rate variability, and heart rate turbulence during evolving reperfused myocardial infarction.
    Ortak J; Weitz G; Wiegand UK; Bode F; Eberhardt F; Katus HA; Richardt G; Schunkert H; Bonnemeier H
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S227-32. PubMed ID: 15683502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable effects of physical training of heart rate variability, heart rate recovery, and heart rate turbulence in chronic heart failure.
    Piotrowicz E; Baranowski R; Piotrowska M; Zieliński T; Piotrowicz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S113-5. PubMed ID: 19250071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin II receptor blockers.
    Spinar J; Vítovec J; Soucek M; Dusek L; Pavlík T;
    Vnitr Lek; 2009 May; 55(5):481-8. PubMed ID: 19514614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure.
    Shehab A; Elnour AA; Struthers AD
    Cardiovasc J Afr; 2008; 19(6):292-6. PubMed ID: 19104723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure.
    Vrtovec B; Okrajsek R; Golicnik A; Ferjan M; Starc V; Radovancevic B
    J Card Fail; 2005 Dec; 11(9):684-90. PubMed ID: 16360963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate turbulence in patients with chronic heart failure.
    Trzos E; Krzemińska-Pakuła M; Rechciński T; Drozdz J; Kurpesa M
    Kardiol Pol; 2008 Nov; 66(11):1183-90; discussion 1191-3. PubMed ID: 19105095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension.
    Chern CM; Hsu HY; Hu HH; Chen YY; Hsu LC; Chao AC
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):169-74. PubMed ID: 16495752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
    Konstam MA; Neaton JD; Poole-Wilson PA; Pitt B; Segal R; Sharma D; Dasbach EJ; Carides GW; Dickstein K; Riegger G; Camm AJ; Martinez FA; Bradstreet DC; Ikeda LS; Santoro EP;
    Am Heart J; 2005 Jul; 150(1):123-31. PubMed ID: 16084158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine and heart rate variability: a marker of dysautonomia in chronic Chagas cardiopathy.
    Cunha AB; Cunha DM; Pedrosa RC; Flammini F; Silva AJ; Saad EA; Kopiler DA
    Rev Port Cardiol; 2003 Jan; 22(1):29-52. PubMed ID: 12712809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ischemia on heart-rate variability in chronic hemodialysis patients.
    Coquet I; Mousson C; Rifle G; Laurent G; Moreau D; Cottin Y; Zeller M; Touzery C; Wolf JE
    Ren Fail; 2005; 27(1):7-12. PubMed ID: 15717628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.